Ex Vivo Rapamycin Generates Apoptosis-Resistant Donor Th2 Cells That Persist In Vivo and Prevent Hemopoietic Stem Cell Graft RejectionJacopo Mariotti, Daniel H. Fowler|The Journal of Immunology|2008Cited by 35
Allogeneic Stem Cell Transplantation As Consolidation Therapy in Patients with Relapsed-Refractory B-Cell Lymphoma Exposed to Bispecific Antibodies: A Study on Behalf of Grupo Español De Transplante y Terapia Celular (GETH-TC)Marta Peña, Alberto Mussetti, Giulia Losi et al.|Blood|2024Cited by 2
Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysisJacopo Mariotti, Stéfania Bramanti, Armando Santoro et al.|British Journal of Haematology|2025Cited by 1
Allogeneic HCT as consolidation in B-cell lymphomas after exposure to bispecific antibodies: a GETH-TC studyMarta Bravo Peña, Alberto Mussetti, Giulia Losi et al.|Blood Advances|2026Cited by 1
Effect of Consolidation with Allogeneic Hematopoietic Cell Transplant Versus No Consolidation in Patients with Non-Hodgkin Lymphomas Treated with Bispecific AntibodiesGiulia Losi, Alberto Mussetti, Eva González‐Barca et al.|Blood|2024Cited by 0